Inhibition of NF-kappaB signaling interferes with phorbol ester-induced growth arrest of keratinocytes in a TNFR1-independent manner.
A skin-specific block in NF-kappaB signaling leads to hyperproliferation of the keratinocytes, inflammation, and spontaneous development of squamous cell carcinoma (SCC). Here we show that an inhibition of NF-kappaB signaling in keratinocytes, via the expression of the super-repressor/ degradation-resistant form of the IkappaBalpha protein (IkappaBalphaDN), interferes with the growth arrest induced by the tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA). The IkappaBalphaDN cells are able to overcome the TPA-induced cell cycle block. Although SCC development as well as hyperproliferation due to IkappaBalphaDN expression in keratinocytes is known to require TNFR1 signaling, the effect of IkappaBalphaDN on phorbol ester signaling is downstream/independent of TNFR1. These data thus identify an interaction between IkappaBalphaDN and the tumor promoter TPA in the growth regulation of keratinocytes. The proposed mechanism is also likely to be significant in the process of cancer development due to NF-kappaB inhibition.
Sur
Inderpreet
I
Department of Bioscience and Nutrition, Karolinska Institutet, Huddinge, Sweden. inderpreet.sur@ki.se
Ulvmar
Maria
M
Jungedal
Roger
R
Toftgård
Rune
R
D000818:Animals; D002273:Carcinogens / Q000494:pharmacology; D002453:Cell Cycle / Q000502:physiology; D002460:Cell Line; D049109:Cell Proliferation; D005260:Female; D006801:Humans; D020672:I-kappa B Proteins / Q000378:metabolism; D015603:Keratinocytes / Q000166:cytology / Q000187:drug effects* / Q000502:physiology*; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D000072000:NF-KappaB Inhibitor alpha; D016328:NF-kappa B / Q000037:antagonists & inhibitors / Q000378:metabolism; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000378:metabolism; D051381:Rats; D047888:Receptors, Tumor Necrosis Factor, Type I / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*
D002273:Carcinogens; D020672:I-kappa B Proteins; D016328:NF-kappa B; C000606204:NFKBIA protein, human; C000606205:Nfkbia protein, mouse; C000606206:Nfkbia protein, rat; D047888:Receptors, Tumor Necrosis Factor, Type I; D000072000:NF-KappaB Inhibitor alpha; D011493:Protein Kinase C; D013755:Tetradecanoylphorbol Acetate